Daily Derivatives: November 19, 2015
Daily Derivatives: November 19, 2015
Daily Derivatives: November 19, 2015
28.1
28.1
27.2
20.8
22.0
23.5
22.4
22.3
22.8
22.6
23.4
22.0
22.0
21.6
21.5
22.4
26-Oct
27-Oct
28-Oct
29-Oct
30-Oct
2-Nov
3-Nov
4-Nov
5-Nov
6-Nov
9-Nov
10-Nov
13-Nov
16-Nov
17-Nov
18-Nov
OI In million
30
25
20
15
10
5
0
8700
8500
8300
8100
7900
7700
7500
7300
Nifty Futures OI
3.7
38.2
65.3
6.9
13.3
48.7
70.6
15.3
50.7
21.8
60.7
44.4
30.9
40.8
16.0
39.7
4.6
3.6
OI in Lacs
CALL
PUT
Fut
COC
Future OI
PCR OI
PCR Vol
7732
7732
0.09
22441125
0.72
0.83
16.09
Previous
7838
7853
7.79
21460425
0.72
0.78
15.39
-1.35%
-1.54%
Change (%)
Pivot levels (NOV)
Nifty future
4.57%
ATM IV
S3
S2
S1
Piv
R1
R2
R3
7511
7641
7686
7771
7816
7901
8031
F&O Highlights
Post a flat start, the Nifty remained lacklustre in the first half. However, sharp
selling was seen in the second half, driving the index 110 points lower towards
the end. India VIX rose 2.6% to 17.4
FIIs sold | 768 crore while DIIs bought | 759 crore in the cash segment. FIIs
bought | 139 crore in index futures and sold | 73 crore in index options. In
stock futures, they bought | 254 crore
The highest Put base is seen at the 7700 strike with 61 lakh shares while the
highest Call base is at the 8000 strike with 71 lakh shares. The 7800 and 7900
Call strikes saw an addition of 14.1 and 6.9 lakh shares, respectively. The 7600
and 7700 Put strikes saw additions of 9.6 and 4.1 lakh shares, respectively
Index Outlook*
Spot
Current
Put (%)
Nifty Future: The Nifty is likely to open gap up on the back of strong global
cues. It is likely to trade in the range of 7700-7810. Buy Nifty in the range of
7725-7735 for targets of 7765-7785, stop loss: 7710
Bank Nifty Future: Despite a sharp fall in the previous session, the banking
index managed to end above the crucial level of 16800. Even though all banking
stocks ended negative, ATM option writing was seen, which indicates towards a
range bound market in the coming days. Buy Bank Nifty in the range of 1676016800, targets: 16900-17000, stop loss: 16710
Stocks Analysis
OI addition: We saw long build-up in Havells, Gail, Petronet LNG and GMR Infra
7600
OI chg %
21.86
IV (%)
15.84
OI chg %
30.72
IV (%)
17.33
7700
54.20
14.97
7.22
15.71
7800
46.45
14.37
-28.85
14.36
7900
15.68
14.56
-5.73
13.96
Biocon whereas long closure was seen in UBL, PNB, Ceat Ltd and CESC
Intraday Recommendation*
8000
6.70
15.32
-13.31
12.42
F&O Turnover
Instrument
while short build-up was seen in OIL, Wipro, Wockhardt Ltd and ITC
OI shedding: We saw short covering in Dabur, Asian Paints, Eicher Motors and
View: Bullish
View: Bearish
No. of Contracts
Turnover (Cr)
%Chg
17315.44
25749.56
26.71
4.43
Target 1: 469
Stock Futures
Index Options
3,11,773
5,19,519
37,82,193
219835
29.45
Stock Options
F&O Total
3,12,347
49,25,832
15946.55
278847
16.11
25.68
Index Futures
FII Activities
(In | crore)
Segment
Buy
Sell
Net
OI (lots)
%Chg
Index futures
1753
1614
139
295576
4.5
Index options
27968
28040
-73
1308808
1.2
Stock futures
3529
3275
254
982201
0.3
Stock options
2517
2630
-113
84319
3.4
35767
35559
208
2670904
1.3
Total
Research Analyst
Amit Gupta
[email protected]
Nandish Patel
[email protected]
Target 2: 474
CMP : 225.5
OI
%Chg
Price
%Chg Symbol
WOCKPHARMA
3109875
20.51
1,592
HAVELLS
5386000
12.16
263
2.3 ABIRLANUVO
IBULHSGFIN
9548000
10.77
605
JPASSOCIAT
174144000
9.24
13
2012800
9.20
141
HINDZINC
-1.1 DABUR
OI
%Chg
Price
%Chg
3000000
-14.14
269
695750
-12.13
1,984
1.0
-2.9 NCC
8312000
-9.49
78
-1.0
-2.7 ENGINERSIN
1577400
0.00
192
-1.8
816500
-4.73
966
-3.2
-4.3 UBL
1.4
Strategy Follow-up
Date
18-Nov-15
18-Nov-15
Stock
JUBFOO
INFTEC
View
Buy
Sell
Strategy
Long Fut
Short Fut
Reco
1398.00
1053.00
Target
1410.00
1046.00
SL
1386.20
1060.50
P&L
-
Comment
Not Initiated
Not Initiated
It is recommended to spread out the trading corpus in a proportionate manner between the various derivatives research
products.
Please avoid allocating the entire trading corpus to a single stock or a single product segment.
Within each product segment it is advisable to allocate equal amount to each recommendation.
For example: The Daily Derivatives product carries 2 intraday recommendations. It is advisable to allocate equal amount
to each recommendation
Allocation
Return Objective
Product wise
allocation
Max allocation
per stock
Number of Calls
Frontline
Stocks
Mid-cap
stocks
Daily Derivatives
5%
Duration
2-3%
2 Stocks
1%
2-3%
Weekly Derivatives
Intraday
10%
3-5%
2 Stocks
3-5%
5-7%
1 Week
High OI stock
5%
2-3%
2-3 Stocks
5-7%
7-10%
1-2 Weeks
Monthly Derivatives
20%
3-5%
4-7 Stocks
7-10%
10-15%
1 Month
Global Derivatives
5%
2-3%
1 Month
10%
2-3%
5-6 Stocks
7-10%
10-15%
3 Months
Alpha Trader
5%
2-3%
5%
3 Months
Products
Volatility Insights
5%
2-3%
1-2 Strategy
8-10%
10-15%
1-2 Month
ArbitrageOpportunity
5%
2-3%
2-3 Stocks
> 2.5%
>2.5%
Event Based
Intraday Futures
10%
2-3%
8-12 Stocks
05.-1%
1-3%
Intraday
15%
3-4%
2-5 Nifty
2-3%
1-14 days
5%
3-4%
2-8 Stocks
3-5%
1-14 days
Page 2
Disclaimer
ANALYST CERTIFICATION
We /I, Amit Gupta B.E, MBA (Finance), Nandish Patel Research Analysts, authors and the names subscribed to this report, hereby certify that all of the views expressed in this research report accurately
reflect our views about the subject issuer(s) or securities. We also certify that no part of our compensation was, is, or will be directly or indirectly related to the specific recommendation(s) or view(s) in this
report.
The information and opinions in this report have been prepared by ICICI Securities and are subject to change without any notice. The report and information contained herein is strictly confidential and
Road
Noway,
7, MIDC
meant solely for the selected recipient and may not be altered
in any
transmitted to, copied or distributed, in part or in whole, to any other person or to the media or reproduced in any form, without
prior written consent of ICICI Securities. While we would endeavour to update the information herein on a reasonable basis, ICICI Securities is under no obligation to update or keep the information
Andheri
(East),
Mumbai 400 093
current. Also, there may be regulatory, compliance or other reasons that may prevent ICICI Securities from doing so. Non-rated securities indicate that rating on a particular security has been suspended
temporarily and such suspension is in compliance with applicable regulations and/or ICICI Securities policies, in circumstances where ICICI Securities might be acting in an advisory capacity to this
company, or in certain other circumstances.
This report is based on information obtained from public sources and sources believed to be reliable, but no independent verification has been made nor is its accuracy or completeness guaranteed. This
report and information herein is solely for informational purpose and shall not be used or considered as an offer document or solicitation of offer to buy or sell or subscribe for securities or other financial
instruments. Though disseminated to all the customers simultaneously, not all customers may receive this report at the same time. ICICI Securities will not treat recipients as customers by virtue of their
receiving this report. Nothing in this report constitutes investment, legal, accounting and tax advice or a representation that any investment or strategy is suitable or appropriate to your specific
circumstances. The securities discussed and opinions expressed in this report may not be suitable for all investors, who must make their own investment decisions, based on their own investment
objectives, financial positions and needs of specific recipient. This may not be taken in substitution for the exercise of independent judgment by any recipient. The recipient should independently evaluate
the investment risks. The value and return on investment may vary because of changes in interest rates, foreign exchange rates or any other reason. ICICI Securities accepts no liabilities whatsoever for
any loss or damage of any kind arising out of the use of this report. Past performance is not necessarily a guide to future performance. Investors are advised to see Risk Disclosure Document to
understand the risks associated before investing in the securities markets. Actual results may differ materially from those set forth in projections. Forward-looking statements are not predictions and may
be subject to
change without notice.
ICICI Securities or its associates might have managed or co-managed public offering of securities for the subject company or might have been mandated by the subject company for any other assignment
in the past twelve months.
ICICI Securities or its associates might have received any compensation from the companies mentioned in the report during the period preceding twelve months from the date of this report for services in
respect of managing or co-managing public offerings, corporate finance, investment banking or merchant banking, brokerage services or other advisory service in a merger or specific transaction.
ICICI Securities or its associates might have received any compensation for products or services other than investment banking or merchant banking or brokerage services from the companies mentioned
in the report in the past twelve months.
ICICI Securities encourages independence in research report preparation and strives to minimize conflict in preparation of research report. ICICI Securities or its analysts did not receive any compensation
or other benefits from the companies mentioned in the report or third party in connection with preparation of the research report. Accordingly, neither ICICI Securities nor Research Analysts have any
material conflict of interest at the time of publication of this report.
It is confirmed that Amit Gupta B.E, MBA (Finance), Nandish Patel, Research Analysts of this report have not received any compensation from the companies mentioned in the report in the preceding
twelve months.
Compensation of our Research Analysts is not based on any specific merchant banking, investment banking or brokerage service transactions.
ICICI Securities or its subsidiaries collectively or Research Analysts do not own 1% or more of the equity securities of the Company mentioned in the report as of the last day of the month preceding the
publication of the research report.
Since associates of ICICI Securities are engaged in various financial service businesses, they might have financial interests or beneficial ownership in various companies including the subject
company/companies mentioned in this report.
It is confirmed that Amit Gupta B.E, MBA (Finance), Nandish Patel, Research Analysts do not serve as an officer, director or employee of the companies mentioned in the report.
ICICI Securities may have issued other reports that are inconsistent with and reach different conclusion from the information presented in this report.
Neither the Research Analysts nor ICICI Securities have been engaged in market making activity for the companies mentioned in the report.
We submit that no material disciplinary action has been taken on ICICI Securities by any Regulatory Authority impacting Equity Research Analysis activities.
This report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such distribution,
publication, availability or use would be contrary to law, regulation or which would subject ICICI Securities and affiliates to any registration or licensing requirement within such jurisdiction. The securities
described herein may or may not be eligible for sale in all jurisdictions or to certain category of investors. Persons in whose possession this document may come are required to inform themselves of and
to observe such restriction.
Page 3